Africa Nuclear Imaging Market Industry Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

Nuclear imaging in the Middle East & Africa covers two primary modalities, SPECT, which holds the larger installed base, and PET, which is growing faster as hybrid PET/CT systems become more accessible. The regional market remains comparatively small relative to North America and Europe but is expanding steadily from a low base. South Africa, Saudi Arabia, the UAE, Egypt, and Israel represent the most developed sub-markets for nuclear imaging technology and services.

Rising incidence of cancer, cardiovascular disease, and neurological disorders across the region is increasing demand for advanced functional imaging. Government investment in healthcare modernization, particularly under Saudi Arabia's Vision 2030 and the UAE's health sector strategies, is supporting the procurement of new imaging systems. A growing supply of medical radioisotopes, including molybdenum-99 and fluorine-18, is also improving access to nuclear imaging procedures.

By product, the market is divided between imaging equipment (SPECT and PET scanners) and radiopharmaceuticals, with equipment representing the larger revenue share. By application, oncology is the dominant clinical use, followed by cardiology and neurology. Geographically, the Gulf Cooperation Council countries lead in equipment spending and per-capita procedure volumes, while North Africa and Sub-Saharan Africa represent emerging markets with lower but rising penetration.

What are the recent trends and outlook?

Adoption of digital PET/CT and SPECT/CT systems is gradually replacing older analog platforms, improving image quality and reducing scan times. There is also growing interest in theranostics, the combined use of diagnostic and therapeutic radiopharmaceuticals, particularly for prostate cancer and neuroendocrine tumors. Looking ahead, the market is expected to reach roughly USD 0.21 billion by 2031, supported by healthcare investment, an expanding private hospital sector, and gradual reimbursement coverage for advanced imaging.